To test the effect of augmenting lymphatic expansion on established kidney disease using a potentially translatable approach, we used a kidney-specific NP to deliver the VEGFR-3 specific mutant of VEGF-C (VEGF-C c156s) in the POD-ATTAC mouse model. Here, VEGFC is linked to kidney disorder.